Retrospective Real-Life Data, Efficacy and Safety of Vismodegib Treatment in Patients with Advanced and Multiple Basal Cell Carcinoma: 3-Year Experience from a Spanish Center.

Angela Ayén-RodríguezLaura Linares-GonzálezCarlos Llamas-SeguraFrancisco Manuel Almazán-FernándezRicardo Ruiz Villaverde

Published in: International journal of environmental research and public health (2023)

Vismodegib is a safe and effective treatment for locally advanced BCC, and its role in unresectable BCC seems to be an important option in these challenging cases.

Keyphrases

basal cell carcinoma
cross sectional
squamous cell carcinoma
combination therapy
machine learning
replacement therapy
artificial intelligence
locally advanced